#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3405831	B	Reversible inhibition of human recombinant MAGL using 2-arachidonoylglycerol substrate assessed as arachidonic acid after 10 mins by HPLC analysis	Homo sapiens	3	ALA3400077	single protein format	Scientific Literature
2.	ALA3405832	B	Reversible inhibition of human recombinant MAGL using 2-arachidonoylglycerol substrate assessed as arachidonic acid after 30 mins by HPLC analysis	Homo sapiens	3	ALA3400077	single protein format	Scientific Literature
3.	ALA3405833	B	Reversible inhibition of human recombinant MAGL using 2-arachidonoylglycerol substrate assessed as arachidonic acid after 60 mins by HPLC analysis	Homo sapiens	3	ALA3400077	single protein format	Scientific Literature
4.	ALA3405834	B	Reversible inhibition of human recombinant MAGL using 2-arachidonoylglycerol substrate assessed as arachidonic acid after 90 mins by HPLC analysis	Homo sapiens	3	ALA3400077	single protein format	Scientific Literature
5.	ALA4718651	B	Inhibition of recombinant dog gastric lipase at 20:1 molar excess compound concentration preincubated for 30 mins at 25 degreeC relative to control	Canis lupus familiaris	10	ALA4715754	single protein format	Scientific Literature
6.	ALA4718652	B	Inhibition of recombinant dog gastric lipase at 4:1 molar excess compound concentration preincubated for 30 mins at 25 degreeC relative to control	Canis lupus familiaris	10	ALA4715754	single protein format	Scientific Literature
7.	ALA4718653	B	Inhibition of recombinant dog gastric lipase preincubated for 30 mins at 25 degreeC	Canis lupus familiaris	10	ALA4715754	single protein format	Scientific Literature
8.	ALA4718654	B	Inhibition of recombinant guinea pig PL-RP2 expressed in Aspergillus oryzae at 4:1 molar excess compound concentration preincubated for 30 mins at 25 degreeC relative to control	Cavia porcellus	10	ALA4715754	assay format	Scientific Literature
9.	ALA4718655	B	Inhibition of recombinant guinea pig PL-RP2 expressed in Aspergillus oryzae at 20:1 molar excess compound concentration preincubated for 30 mins at 25 degreeC relative to control	Cavia porcellus	10	ALA4715754	assay format	Scientific Literature
10.	ALA4718656	B	Inhibition of recombinant guinea pig PL-RP2 expressed in Aspergillus oryzae preincubated for 30 mins at 25 degreeC	Cavia porcellus	10	ALA4715754	assay format	Scientific Literature
11.	ALA4718657	B	Inhibition of porcine pancreatic lipase at 400:1 molar excess compound concentration preincubated for 30 mins at 25 degreeC relative to control	Sus scrofa	14	ALA4715754	single protein format	Scientific Literature
12.	ALA4718658	B	Inhibition of porcine pancreatic lipase preincubated for 30 mins at 25 degreeC	Sus scrofa	14	ALA4715754	single protein format	Scientific Literature
13.	ALA4718659	B	Inhibition of human pancreatic lipase at 400:1 molar excess compound concentration preincubated for 30 mins at 25 degreeC relative to control	Homo sapiens	14	ALA4715754	single protein format	Scientific Literature
14.	ALA4718660	B	Inhibition of human pancreatic lipase preincubated for 30 mins at 25 degreeC	Homo sapiens	14	ALA4715754	single protein format	Scientific Literature
15.	ALA5113633	B	Inhibition of Mycobacterium tuberculosis Lipy assessed as pomegranate oil TAG lipolysis at 4 times molar excess of inhibitor concentration related to 1 mole of enzyme incubated for 30 mins by microtitre plate assay	Mycobacterium tuberculosis	20	ALA5113371	assay format	Scientific Literature
16.	ALA5113634	B	Inhibition of Mycobacterium tuberculosis Lipy assessed as pomegranate oil TAG lipolysis at 20 times molar excess of inhibitor concentration related to 1 mole of enzyme incubated for 30 mins by microtitre plate assay	Mycobacterium tuberculosis	20	ALA5113371	assay format	Scientific Literature
17.	ALA5113635	B	Inhibition of Mycobacterium tuberculosis Lipy incubated for 30 mins by UV spectrophotometric analysis	Mycobacterium tuberculosis	20	ALA5113371	assay format	Scientific Literature